Which of the following antidiabetic medication works by decreasing glucose reabsorption?
Suggested Answer: C
Get Premium NAPLEX Questions
as Interactive Web-Based Practice Test or PDF
Real Exam Format
Detailed Explanations
Instant Access
Get Your Practice Test
Omeprazole is CYP2C19 inhibitor which can prolong the elimination of warfarin, particularly R-warfarin. R- warfarin is partially metabolized by CYP2C19. The combined use of omeprazole and warfarin has been associated with reports of increased INR and prothrombin time (PT).
31 comments · newest first
AI
Aileen
10 months ago
Yup, definitely Empagliflozin!
JA
Javier
11 months ago
I thought Pioglitazone was the answer, but I guess not.
PA
Paola
11 months ago
Wait, isn't that just for glucose excretion?
CL
Clarence
11 months ago
Totally agree, it's an SGLT2 inhibitor.
LE
Lera
11 months ago
Empagliflozin is the one that decreases glucose reabsorption!
RA
Rasheeda
12 months ago
I practiced a similar question where Empagliflozin was mentioned as an SGLT2 inhibitor, which is related to glucose reabsorption.
BE
Becky
12 months ago
Linagliptin is a DPP-4 inhibitor, right? I feel like I might be mixing up the mechanisms here.
CL
Clay
12 months ago
I remember studying that Miglitol is an alpha-glucosidase inhibitor, so it doesn't fit this question.
LI
Ligia
1 year ago
I think Empagliflozin is the one that decreases glucose reabsorption, but I'm not completely sure.
EV
Evangelina
1 year ago
I've got this! Empagliflozin is the SGLT2 inhibitor that reduces glucose reabsorption, so that's got to be the right answer.
AL
Alexis
1 year ago
I'm a bit confused by the options, but I think I can eliminate a few based on their known mechanisms. Let me think this through step-by-step.
LI
Ligia
1 year ago
Okay, I remember learning about SGLT2 inhibitors like empagliflozin that work by decreasing glucose reabsorption in the kidneys. That seems like the most likely answer here.
AL
Alfred
1 year ago
Hmm, I'm not too familiar with the specific mechanisms of these drugs. I'll have to think this through carefully.
YU
Yuette
1 year ago
This looks like a pharmacology question, so I'll need to recall my knowledge of different antidiabetic medications and their mechanisms of action.
JO
Johnetta
1 year ago
Empagliflozin FTW! I'm gonna crush this exam. Now, where did I put my lucky rabbit's foot?
AF
Afton
1 year ago
Hmm, Pioglitazone is a thiazolidinedione that works on insulin sensitivity. I don't think that's the right answer for decreasing glucose reabsorption.
LU
Luis
1 year ago
User 3: Yeah, Pioglitazone works on insulin sensitivity, not glucose reabsorption.
ID
Idella
1 year ago
User 2: I agree, Empagliflozin works by decreasing glucose reabsorption.
CH
Chauncey
1 year ago
User 1: I think the answer is E) Empagliflozin.
CH
Chau
1 year ago
I'm pretty sure Exenatide is a GLP-1 agonist, not a glucose reabsorption inhibitor. Maybe I should have paid more attention in pharmacology class.
HA
Han
1 year ago
User 3: So, which medication actually works by decreasing glucose reabsorption?
PR
Precious
1 year ago
You're right, Exenatide is a GLP-1 agonist.
LO
Loreen
1 year ago
E) Empagliflozin works by inhibiting SGLT2.
CE
Cecily
1 year ago
User 2: Yeah, it doesn't decrease glucose reabsorption.
SE
Serina
1 year ago
B) Linagliptin is a DPP-4 inhibitor.
SA
Santos
1 year ago
User 1: I think you're right, Exenatide is a GLP-1 agonist.
SO
Sommer
1 year ago
A) Miglitol works by decreasing glucose reabsorption.
TE
Tegan
1 year ago
Empagliflozin, the SGLT2 inhibitor, is the correct answer. It works by decreasing glucose reabsorption in the kidneys. Gotta love those diuretic effects!
RE
Remedios
2 years ago
I'm not sure, but I think A) Miglitol also works by decreasing glucose reabsorption by inhibiting enzymes in the intestines.
TR
Truman
2 years ago
I agree with Carmen, Empagliflozin is a SGLT2 inhibitor that helps lower blood sugar levels by causing the kidneys to remove sugar through urine.
CA
Carmen
2 years ago
I think the answer is E) Empagliflozin because it works by decreasing glucose reabsorption.